Class information for:
Level 1: FUMARIC ACID ESTERS//DIMETHYL FUMARATE//DIMETHYLFUMARATE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23949 275 33.0 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
669 12548 PSORIASIS//PSORIATIC ARTHRITIS//CALCIPOTRIOL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FUMARIC ACID ESTERS Author keyword 35 67% 11% 31
2 DIMETHYL FUMARATE Author keyword 29 48% 16% 44
3 DIMETHYLFUMARATE Author keyword 21 69% 7% 18
4 MONOMETHYLFUMARATE Author keyword 9 83% 2% 5
5 BG 12 Author keyword 6 47% 3% 9
6 FUMARATES Author keyword 5 55% 2% 6
7 FUMARIC ACID ESTER Author keyword 3 57% 1% 4
8 BIOMED PNEUMOL Address 2 67% 1% 2
9 SOFA DERMATITIS Author keyword 2 67% 1% 2
10 DELAYED RELEASE DIMETHYL FUMARATE Author keyword 2 50% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 FUMARIC ACID ESTERS 35 67% 11% 31 Search FUMARIC+ACID+ESTERS Search FUMARIC+ACID+ESTERS
2 DIMETHYL FUMARATE 29 48% 16% 44 Search DIMETHYL+FUMARATE Search DIMETHYL+FUMARATE
3 DIMETHYLFUMARATE 21 69% 7% 18 Search DIMETHYLFUMARATE Search DIMETHYLFUMARATE
4 MONOMETHYLFUMARATE 9 83% 2% 5 Search MONOMETHYLFUMARATE Search MONOMETHYLFUMARATE
5 BG 12 6 47% 3% 9 Search BG+12 Search BG+12
6 FUMARATES 5 55% 2% 6 Search FUMARATES Search FUMARATES
7 FUMARIC ACID ESTER 3 57% 1% 4 Search FUMARIC+ACID+ESTER Search FUMARIC+ACID+ESTER
8 SOFA DERMATITIS 2 67% 1% 2 Search SOFA+DERMATITIS Search SOFA+DERMATITIS
9 DELAYED RELEASE DIMETHYL FUMARATE 2 50% 1% 3 Search DELAYED+RELEASE+DIMETHYL+FUMARATE Search DELAYED+RELEASE+DIMETHYL+FUMARATE
10 ANTI MOULD AGENT 1 100% 1% 2 Search ANTI+MOULD+AGENT Search ANTI+MOULD+AGENT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MONOMETHYLFUMARATE 62 90% 10% 27
2 DIMETHYLFUMARATE 35 73% 10% 27
3 FUMARIC ACID ESTERS 15 31% 14% 39
4 ORAL BG 12 13 42% 9% 24
5 PLACEBO CONTROLLED PHASE 3 12 31% 12% 34
6 FUMARIC ACID DERIVATIVES 11 65% 4% 11
7 DIMETHYL FUMARATE 7 36% 6% 16
8 NRF2 ANTIOXIDANT PATHWAY 4 56% 2% 5
9 ORAL FUMARATE 3 100% 1% 3
10 HYPERPROLIFERATIVE KERATINOCYTES 3 60% 1% 3

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview 2015 1 37 70%
Dimethyl fumarate for treating relapsing multiple sclerosis 2015 2 36 39%
Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects 2013 8 42 69%
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis 2014 7 46 46%
Dimethylfumarate for psoriasis: more than a dietary curiosity 2005 76 40 58%
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety 2014 11 49 29%
Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action 2012 24 28 89%
Fumaric acid esters, their place in the treatment of psoriasis 2004 19 14 100%
Mode of action and clinical studies with fumarates in multiple sclerosis 2014 4 42 52%
Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis 2014 5 34 44%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOMED PNEUMOL 2 67% 0.7% 2
2 UNIV CLIN BOCHUM 1 100% 0.7% 2
3 PSORIASIS ZENTRUM 1 27% 1.1% 3
4 PSORIASIS 1 12% 2.5% 7
5 ABT ALLERGOL BERUFS UMWELTDERMATOL 1 50% 0.4% 1
6 DEV TRANSLAT MED 1 50% 0.4% 1
7 DRUG SAFE 1 50% 0.4% 1
8 INTERNAL MED AGING METAB 1 50% 0.4% 1
9 PUBL HLTHDRUG MANAGEMENT 1 50% 0.4% 1
10 AGENTS INFECT PHARMACOL TOXICOL 0 33% 0.4% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000134683 POLYUNSATURATED FREE FATTY ACID//BRUSH BORDERS//ISF PHARM
2 0.0000123847 GLATIRAMER ACETATE//INTERFERON BETA//INTERFERON BETA 1B
3 0.0000116972 PSORIASIS//TAIYUAN CITY HOSP//MOUSE TAIL TEST
4 0.0000088443 NRF2//KEAP1//ANTIOXIDANT RESPONSE ELEMENT
5 0.0000072202 NEUROREHABIL WARD//PERINATAL BIOCHEM//ASTROCYTE SURVIVAL
6 0.0000071161 CHILDHOOD PSORIASIS//JUVENILE PSORIASIS//PERIANAL STREPTOCOCCAL DERMATITIS
7 0.0000060866 PSORIASIS//EFALIZUMAB//ALEFACEPT
8 0.0000058607 UNIT MULTIDISCIPLINARY INVEST BIOMED//PSORIATIC NEPHROPATHY//DERMATOL VENEREOL PAEDIAT DERMATOL
9 0.0000057387 GRANULOMA ANNULARE//NECROBIOSIS LIPOIDICA//SUBCUTANEOUS GRANULOMA ANNULARE
10 0.0000054865 LAROPIPRANT//NIACIN//HM74A